Neutrolis | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25 results for “Neutrolis”

Trials

View all 10 →

Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection

806 participants · First posted Jan 11, 2016

Neutrolin Versus Heparin for Locking Hemodialysis Catheters

192 participants · First posted Feb 7, 2018

Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

400 participants · First posted Jun 21, 2021

Drugs

L303

Neutrolide

OPNT002 (Neurelis)

Organizations

NEUTROLIS, INC.

United States

Neurelis, Inc.

United States

Neuralis S.A.

Chile

News

Neutrolis Reports Positive Phase 1a Results for First-in-Class NET-Targeting Therapy NTR-1011

Neutrolis to Present Early Human Proof-of-Concept Data for Novel NET-Targeting Therapy at ACR 2025

Avextra's Cannabis-Based Medicine Enters Phase 2 Trial for Neurodegenerative Diseases

Page 1 of 3